ReviewCurrent oncology reports2026
Status of Integrative Oncology in Low- and Middle-Income Countries of East and Southeast Asia.
Review in Current oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purpose of the reviewPatients with cancer often choose to use traditional and complementary medicine in addition to conventional treatments. To assess the current status of integrative oncology (IO) worldwide including low- and middle-income countries (LMICs), the Society for Integrative Oncology (SIO) Global Committee launched a review program in 2024. This review examines the status of IO in LMICs across East and Southeast Asia, including Mongolia, Democratic People’s Republic of Korea (DPRK), Timor-Leste, Cambodia, Lao People’s Democratic Republic (LPDR), Myanmar, Vietnam, Indonesia, the Philippines, Thailand, and Malaysia. By analyzing historical backgrounds, hospital systems, education and research endeavors, and government support in IO, this review seeks to outline the current status while identifying challenges and future prospects for IO integration in these regions. RECENT
findingsDespite the widespread use of traditional medicine in East and Southeast Asian LMICs, most countries lack significant IO services, except Thailand and Malaysia. Preliminary information suggests some IO practices in countries such as Mongolia. There are ongoing efforts in Cambodia and Philippines, while some countries like Myanmar and Timor-Leste lag behind in IO development. Key challenges include limited research on IO, educational gaps, and inadequate national policies supporting IO. This narrative review provides insights into the present state of IO in East and Southeast Asian LMICs, highlighting the need for expanded cross-national research partnerships, educational initiatives, and stronger government support to facilitate the integration of traditional therapies into cancer care frameworks.
Indexed as
Identifiers
41718925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.